Speech in Commons Chamber - Fri 21 Nov 2014
National Health Service (Amended Duties and Powers) Bill
"Although I do not agree with the hon. Gentleman on many things, I welcome him back to the House. He has talked about the history and the evidence. He might be interested to know that, according to the House of Commons Library, the amount spent by NHS England on buying …..."Julian Huppert - View Speech
View all Julian Huppert (LD - Cambridge) contributions to the debate on: National Health Service (Amended Duties and Powers) Bill
Speech in Commons Chamber - Fri 21 Nov 2014
National Health Service (Amended Duties and Powers) Bill
"Will the hon. Gentleman give way?..."Julian Huppert - View Speech
View all Julian Huppert (LD - Cambridge) contributions to the debate on: National Health Service (Amended Duties and Powers) Bill
Speech in Commons Chamber - Fri 21 Nov 2014
National Health Service (Amended Duties and Powers) Bill
"My hon. Friend will be well aware that there have been many trials of homeopathic medicines, and the fact is that none of them has shown that they work better than a placebo. He is right that they are very dilute; that is why they do not work...."Julian Huppert - View Speech
View all Julian Huppert (LD - Cambridge) contributions to the debate on: National Health Service (Amended Duties and Powers) Bill
Speech in Commons Chamber - Fri 21 Nov 2014
National Health Service (Amended Duties and Powers) Bill
"The right hon. Gentleman correctly says that the contract for Hinchingbrooke was let under this Government, but does he not accept that it was he who, when Health Secretary, reduced the list of bidders to five, none of which were NHS bidders, and then to three, all of which were …..."Julian Huppert - View Speech
View all Julian Huppert (LD - Cambridge) contributions to the debate on: National Health Service (Amended Duties and Powers) Bill
Speech in Commons Chamber - Fri 21 Nov 2014
National Health Service (Amended Duties and Powers) Bill
"Will the right hon. Gentleman give way?..."Julian Huppert - View Speech
View all Julian Huppert (LD - Cambridge) contributions to the debate on: National Health Service (Amended Duties and Powers) Bill
Speech in Commons Chamber - Fri 21 Nov 2014
National Health Service (Amended Duties and Powers) Bill
"On a point of order, Madam Deputy Speaker. The right hon. Gentleman claimed earlier that one of the bidders at Hinchingbrooke was an NHS provider, but according to the National Audit Office there was Circle, Serco and Ramsay. Can he now either correct the record for the House, or let …..."Julian Huppert - View Speech
View all Julian Huppert (LD - Cambridge) contributions to the debate on: National Health Service (Amended Duties and Powers) Bill
Speech in Commons Chamber - Fri 21 Nov 2014
National Health Service (Amended Duties and Powers) Bill
"I was delighted with that outcome. One of the successes I hope the hon. and learned Gentleman will mention is the better joint working between acute care, mental health care and community services to avoid delays in the transfer of care. This could be a very good outcome for the …..."Julian Huppert - View Speech
View all Julian Huppert (LD - Cambridge) contributions to the debate on: National Health Service (Amended Duties and Powers) Bill
Written Question
Monday 10th November 2014
Asked by:
Julian Huppert (Liberal Democrat - Cambridge)
Question
to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many times he has exercised his powers under the National Institute for Health and Care Excellence (Constitution and Functions) and the Health and Social Care Information Centre (Functions) Regulations 2013 to refer an unlicensed indication of a drug for a NICE technology appraisal.
Answered by George Freeman
Since the ‘National Institute for Health and Care Excellence (Constitution and Functions) and the Health and Social Care Information Centre (Functions) Regulations 2013’ came into force on 1 April 2013, the Department has not asked the National Institute for Health and Care Excellence (NICE) to develop under Regulation 7 any technology appraisal guidance on the use of an unlicensed drug. The Department has, however, under Regulation 5, asked NICE to develop guidance and recommendations on the use of a combination therapy for use in the treatment of ovarian cancer outside the terms of its marketing authorisation.
Written Question
Monday 10th November 2014
Asked by:
Julian Huppert (Liberal Democrat - Cambridge)
Question
to the Department of Health and Social Care:
To ask the Secretary of State for Health, what discussions he has had with (a) charities and (b) clinicians who support the Off-patent Drugs Bill.
Answered by George Freeman
Departmental Ministers have met with the hon. Member for Cardiff North (Jonathan Evans), with regard to his Off-Patent Drugs Bill and officials have also had discussions with Breast Cancer Campaign to understand their concerns around the prescribing of off-patent drugs and the implications for patients.
We are in the process of setting up a round-table discussion with key stakeholders, NHS England and the National Institute for Health and Care Excellence to review the evidence and develop a strategy to better support use of off-label medicines in areas where the evidence suggests that they can deliver patient benefit.
Written Question
Monday 3rd November 2014
Asked by:
Julian Huppert (Liberal Democrat - Cambridge)
Question
to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the Answer of 22 October 2014 to Question 210807, what the anticipated payments were in respect of England in 2014-15; whether the anticipated payments have been passed to NHS England through the mandate; and whether the actual rebate payments for 2014-15 are on course to match or exceed those anticipated payments.
Answered by George Freeman
The anticipated Pharmaceutical Price Regulation Scheme (PPRS) payment for 2014-15 in respect of England was estimated to be £375 million and this was taken into account when setting the 2014-15 NHS England Mandate and overall NHS budget.
The actual amount received in financial year 2014-15 will depend on actual sales covered by the PPRS in Quarters 2-4 2014 and Quarter 1 in 2015, and also on the adjusted payment percentage for 2015 which will affect Quarter 1 2015.
The Government has committed to publishing PPRS payment data quarterly. In line with this commitment, the Department has published the first two quarters PPRS payments for 2014 and will be announcing the third and fourth quarter payments, which will depend on growth in those quarters, together with the adjusted payment percentage for 2015, in due course.